Fresenius BCM Body Composition Monitor - HSA Registration DE0500409
Access comprehensive regulatory information for Fresenius BCM Body Composition Monitor in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0500409 and owned by Fresenius Medical Care AG. The device was registered on April 01, 2016.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The BCM - Body Composition Monitor assists the physician in assessing the hydration status by a bioimpedance spectroscopy measurement of the body composition from which the level of overhydration can be derived. Apart from the hydration status, the device also determines the patient's nutritional condition. The device permits continuous monitoring of the body composition and provides an objective indicator for the nutritional condition: the LTI (Lean Tissue Index) and the FTI (Fat Tissue Index). The BCM - Body Composition Monitor also determines of the urea distribution volume to calculate the dialysis dose (Kt/V). The BCM - Body Composition Monitor is intended for screening and monitoring of patients with renal diseases within the scope of dialysis therapy and extracorporeal therapies. It can be used in dialysis centers, hospitals, medical practices.